Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement

被引：0
|
作者：
Vicente Molina
Juan D. Gispert
Santiago Reig
Javier Sanz
Javier Pascau
Andrés Santos
Manuel Desco
Tomás Palomo
机构：
[1] Hospital Doce de Octubre,Department of Psychiatry
[2] Servicio de Psiquiatría,Department of Psychiatry, Hospital Clínico Universitario
[3] Hospital General Universitario Gregorio Marañón,Department of Experimental Medicine
[4] Universidad Politécnica,Department of Electrical Engineering
来源：
Psychopharmacology | 2005年 / 178卷
关键词：
Brain metabolism; (FDG)-PET; Hypofrontality; Haloperidol; Clozapine; SPM;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 26
页数：9
相关论文
共 50 条
  • [1] Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement
    Molina, V
    Gispert, JD
    Reig, S
    Sanz, J
    Pascau, J
    Santos, A
    Desco, M
    Palomo, T
    [J]. PSYCHOPHARMACOLOGY, 2005, 178 (01) : 17 - 26
  • [2] Olanzapine-induced cerebral metabolic changes related to symptom improvement in schizophrenia
    Molina, V
    Gispert, JD
    Reig, S
    Pascau, J
    Martínez, R
    Sanz, J
    Palomo, T
    Desco, M
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (01) : 13 - 18
  • [3] Olanzapine-induced cerebral metabolic changes related to PANSS in first-episode schizophrenia
    Fujita, S.
    Yoshimuta, H.
    Takeuchi, K.
    Fujimoto, T.
    Sano, A.
    Nagamachi, S.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S621 - S621
  • [4] Relationship between clinical improvement and functional gains with clozapine in schizophrenia
    Lee, Jimmy
    Takeuchi, Hiroyoshi
    Fervaha, Gagan
    Bhaloo, Amaal
    Powell, Valerie
    Remington, Gary
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (10) : 1622 - 1629
  • [5] CEREBRAL MORPHOMETRY AND CLOZAPINE TREATMENT IN SCHIZOPHRENIA
    BILDER, RM
    WU, HW
    CHAKOS, MH
    BOGERTS, B
    POLLACK, S
    ARONOWITZ, J
    ASHTARI, M
    DEGREEF, G
    KANE, JM
    LIEBERMAN, JA
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 1994, 55 (09) : 53 - 56
  • [6] INDUCED METABOLIC CHANGES FOR YIELD IMPROVEMENT
    TSCHABOLD, EE
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1975, 170 (AUG24): : 96 - 96
  • [7] Comparison of metabolic changes between patients with schizophrenia taking clozapine and the other antipsychotics
    Lee, N. Y.
    Kim, S. H.
    Shin, S. Y.
    Ahn, Y. M.
    Kang, U. G.
    Youn, T.
    Chung, I. W.
    Kim, Y. S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S335 - S335
  • [8] CHANGES IN RORSCHACH PERFORMANCE AND CLINICAL IMPROVEMENT IN SCHIZOPHRENIA
    GOLDMAN, R
    [J]. JOURNAL OF CONSULTING PSYCHOLOGY, 1960, 24 (05): : 403 - 407
  • [9] Clinical improvement and metabolic effects of antipsychotic drugs in schizophrenia
    Olszewska, K.
    Rybakowski, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S414 - S415
  • [10] Topiramate Augmentation in Clozapine-Treated Patients With Schizophrenia Clinical and Metabolic Effects
    Hahn, Margaret K.
    Remington, Gary
    Bois, Daniel
    Cohn, Tony
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (06) : 706 - 710
12345